X

rhodiola-rosea-subjective-well-being

Therapeutic Effects And Safety Of Rhodiola Rosea Extract WS® 1375 In Subjects With Life-stress Symptoms–results Of An Open-label Study

効果 増加
試験方法 コホート法
試験期間 2-4 週間
被験者数 82
性別 男女
年齢 30-44, 45-64
体型 肥満
この研究の注釈:

200mg of rhodiola extract (300-1000mg root equivalent) twice daily for 4 weeks in persons with life and work-related stress was greatly able to reduce dysfunction and fatigue associated with stress in a time-dependent manner. Significant improvements were noted in social and work function secondary to reduced fatigue and improved mood.


A Double-blind, Placebo-controlled Pilot Study Of The Stimulating And Adaptogenic Effect Of Rhodiola Rosea SHR-5 Extract On The Fatigue Of Students Caused By Stress During An Examination Period With A Repeated Low-dose Regimen
効果 増加
試験方法 二重盲検法
試験期間 2-4 週間
被験者数 40
性別 男性
年齢 13-17, 18-29
体型 平均
この研究の注釈:

20 days of rhodiola supplementation during examination periods for students (100mg SHR-5) was able to improve neuromotoric fitness (accuracy of maze drawing test), fatigue, and well being relative to placebo. Exam scores were 8.4% higher in the rhodiola group relative to placebo.


A Randomized Trial Of Two Different Doses Of A SHR-5 Rhodiola Rosea Extract Versus Placebo And Control Of Capacity For Mental Work
効果 増加
試験方法 二重盲検法
試験期間 1-7 Days
被験者数 121
性別 男性
年齢 18-29
体型 トレーニング中, 肥満, 平均
この研究の注釈:

In military cadets performing regular military night duties, 5 days of supplementation of rhodiola (370 or 555mg of SHR-5) was able to significantly reduce total fatigue and improve well being when measured 2 hours after supplement ingestion and again at the end of the trial. Capacity for mental work significantly increased relative to placebo.


Clinical Trial Of Rhodiola Rosea L. Extract SHR-5 In The Treatment Of Mild To Moderate Depression
効果 増加
試験方法 二重盲検法
試験期間 1-6 ヶ月
被験者数 89
性別 男女
年齢 18-29, 30-44, 45-64
この研究の注釈:

42 days supplementation of 340-680mg rhodiola SHR-5 extract was able to significantly reduce the symptoms of depression in persons with diagnosed depression, with only partial dose dependence noted.

The degree of improvement ranged from 30-35% (HAMD rating scale) to 50% reduced symptoms (higher dose on BDI).


管理人 :慶應義塾大学の理工学部卒業後、国内外でコンサルティング業務やスタートアップの立ち上げを経験した後、日本に帰国してから健康・医療の情報を収集して発信しています。 趣味:ネットサーフィン、読書(最近かなり減ってますが)、アウトドア(家族と) 毎日メディテーションとジョギング、筋トレ・ストレッチしています。既婚で子供4人(男女女男)です。